Jonathan Yong
Stock Analyst at UBS
(2.59)
# 2,149
Out of 4,896 analysts
104
Total ratings
60%
Success rate
10.49%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $9.5 → $7 | $3.89 | +79.95% | 5 | May 8, 2025 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $2.92 | +36.99% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $14.38 | +59.94% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $21.08 | +18.60% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.52 | +160.42% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $7.05 | +70.21% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.75 | +68.60% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $12.07 | +115.41% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $47.89 | -70.77% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $73.44 | +30.73% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $14.74 | +117.10% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $21.16 | +396.22% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $118.43 | -32.45% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $249.62 | -7.46% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $97.17 | +3.94% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $8.32 | +224.52% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $160.97 | -37.88% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $709.59 | -36.58% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $3.92 | +206.12% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $8.40 | +733.33% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $13.52 | +25.74% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $221.55 | +57.98% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $24.36 | +289.98% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $5.93 | +43.34% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $20.47 | +100.34% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $8.12 | +109.36% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.60 | +136.11% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $80.77 | +5.24% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $168.09 | -13.14% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $31.44 | +237.15% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $182.52 | -13.98% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $303.27 | +21.34% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $230.67 | +175.29% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $64.78 | +80.61% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $13.12 | +128.66% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $376.07 | -20.76% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $175.75 | -45.95% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $304.10 | +62.78% | 1 | Oct 15, 2021 |
eHealth
May 8, 2025
Maintains: Neutral
Price Target: $9.5 → $7
Current: $3.89
Upside: +79.95%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $2.92
Upside: +36.99%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $14.38
Upside: +59.94%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $21.08
Upside: +18.60%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.52
Upside: +160.42%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $7.05
Upside: +70.21%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.75
Upside: +68.60%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $12.07
Upside: +115.41%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $47.89
Upside: -70.77%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $73.44
Upside: +30.73%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $14.74
Upside: +117.10%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $21.16
Upside: +396.22%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $118.43
Upside: -32.45%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $249.62
Upside: -7.46%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $97.17
Upside: +3.94%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $8.32
Upside: +224.52%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $160.97
Upside: -37.88%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $709.59
Upside: -36.58%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $3.92
Upside: +206.12%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $8.40
Upside: +733.33%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $13.52
Upside: +25.74%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $221.55
Upside: +57.98%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $24.36
Upside: +289.98%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $5.93
Upside: +43.34%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $20.47
Upside: +100.34%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $8.12
Upside: +109.36%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.60
Upside: +136.11%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $80.77
Upside: +5.24%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $168.09
Upside: -13.14%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $31.44
Upside: +237.15%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $182.52
Upside: -13.98%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $303.27
Upside: +21.34%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $230.67
Upside: +175.29%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $64.78
Upside: +80.61%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $13.12
Upside: +128.66%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $376.07
Upside: -20.76%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $175.75
Upside: -45.95%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $304.10
Upside: +62.78%